LifeMD, Inc.
LFMD Healthcare Health Information Services
LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow LFMD
LifeMD, Inc. (LFMD) EV/Sales
As of 16 October 2026, LifeMD, Inc. (LFMD) trades at a EV/Sales of 0.5×. Over the past ten years it has ranged from 0.3× (March 2023) to 11.5× (February 2021); the current reading is higher than 9% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.7× | (44.21%) |
| FY2024 | 1.2× | (31.26%) |
| FY2023 | 1.8× | 261.12% |
| FY2022 | 0.5× | (29.56%) |
| FY2021 | 0.7× | (69.31%) |
| FY2020 | 2.3× | 401.19% |
| FY2019 | 0.5× | (37.55%) |
| FY2018 | 0.7× | (82.09%) |
| FY2017 | 4.1× | 168.10% |
| FY2016 | 1.5× | (46.59%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.0× | 24.71% |
| Mar 2026 | 0.8× | 14.99% |
| Dec 2025 | 0.7× | (62.65%) |
| Sep 2025 | 1.8× | (49.91%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AMWL American Well Corporation compare | 0.0× |
| DH Definitive Healthcare Corp. compare | 0.4× |
| SY So-Young International Inc. Sponsored ADR compare | 0.5× |
| LFMD LifeMD, Inc. | 0.5× |
| HCAT Health Catalyst, Inc. compare | 0.6× |
| CCLD CareCloud, Inc. compare | 0.8× |
| SPOK Spok Holdings, Inc. compare | 1.5× |
| OPRX OptimizeRx Corp. compare | 1.6× |
| DRIO DarioHealth Corp. compare | 3.5× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)